Publicado por John Wiley and Sons,, 1997
Librería: Plum Books, St. Paul, MN, Estados Unidos de America
EUR 16,67
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Fair. No Jacket. Ex-library copy with usual marks,clean and tight but for library marks, no dust jacket. INV#J-34.
Idioma: Inglés
Publicado por Oxford University Press, Oxford, United Kingdom, 1974
ISBN 10: 0198554540 ISBN 13: 9780198554547
Librería: PsychoBabel & Skoob Books, Didcot, Reino Unido
EUR 22,77
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Estado de la sobrecubierta: Very Good. Clean and unmarked.
Librería: WorldofBooks, Goring-By-Sea, WS, Reino Unido
EUR 39,32
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Librería: Plurabelle Books Ltd, Cambridge, Reino Unido
Miembro de asociación: GIAQ
Ejemplar firmado
EUR 38,15
Cantidad disponible: 1 disponibles
Añadir al carritoHardback. Condición: As New. x 218p hardback, blue and grey cover, like new condition, little to no wear, binding tight, pages clean and bright like new, author's signature on the front endpaper Language: English.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 51,90
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Wiley-Blackwell 3/2/2015, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Librería: BargainBookStores, Grand Rapids, MI, Estados Unidos de America
EUR 54,25
Cantidad disponible: 5 disponibles
Añadir al carritoHardback or Cased Book. Condición: New. Off-Label Prescribing: Justifying Unapproved Medicine. Book.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 52,90
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por John Wiley and Sons Ltd, GB, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 56,41
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients. But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview. Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice. The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
Librería: AwesomeBooks, Wallingford, Reino Unido
EUR 55,03
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Off-label Prescribing: Justifying Unapproved Medicine This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .
EUR 55,03
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 50,46
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 50,45
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 55,10
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por John Wiley and Sons Ltd, GB, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Librería: Rarewaves.com UK, London, Reino Unido
EUR 52,53
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients. But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview. Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice. The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
Idioma: Inglés
Publicado por John Wiley & Sons Mär 2015, 2015
ISBN 10: 1118912071 ISBN 13: 9781118912072
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 71,41
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients.But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview.Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice.The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.
Idioma: Inglés
Publicado por Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 207,12
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Royal Society of Chemistry, GB, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: Rarewaves USA, OSWEGO, IL, Estados Unidos de America
EUR 209,47
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical RandD, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
EUR 215,79
Cantidad disponible: 15 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
EUR 223,29
Cantidad disponible: 15 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 213,87
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 231,69
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 240,04
Cantidad disponible: 15 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 238,59
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new.
Idioma: Inglés
Publicado por Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 237,77
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 250,87
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Royal Society of Chemistry, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 236,30
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 240,03
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Royal Society of Chemistry, GB, 2022
ISBN 10: 1788019032 ISBN 13: 9781788019033
Librería: Rarewaves USA United, OSWEGO, IL, Estados Unidos de America
EUR 213,88
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical RandD, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 245,97
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 272,87
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.